Form 8-K - Current report:
SEC Accession No. 0001178913-24-003766
Filing Date
2024-11-19
Accepted
2024-11-19 16:06:30
Documents
14
Period of Report
2024-11-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K zk2432357.htm   iXBRL 8-K 52471
  Complete submission text file 0001178913-24-003766.txt   235195

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA slxn-20241119.xsd EX-101.SCH 4740
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE slxn-20241119_def.xml EX-101.DEF 18263
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE slxn-20241119_lab.xml EX-101.LAB 27748
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slxn-20241119_pre.xml EX-101.PRE 20505
17 EXTRACTED XBRL INSTANCE DOCUMENT zk2432357_htm.xml XML 6551
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42253 | Film No.: 241476051
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)